Jci_page_head_homepage_01 Jci_page_head_homepage_02
Christophe Ginestier, Suling Liu, Mark E. Diebel, Hasan Korkaya, Ming Luo, Marty Brown, Julien Wicinski, Olivier Cabaud, Emmanuelle Charafe-Jauffret, Daniel Birnbaum, Jun-Lin Guan, Gabriela Dontu, Max S. Wicha
Published in Volume 120, Issue 2
J Clin Invest. 2010; 120(2):485–497 doi:10.1172/JCI39397
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 1
Effect of CXCR1 blockade on cell viability and on the ALDEFLUOR+ population in vitro.

(A) Representation of the overlap between the ALDEFLUOR+ subpopulation and the CXCR1+ (top) or CXCR2+ (bottom) subpopulation of SUM159 cells. (B and C) SUM159 cells were cultured in adherent conditions and treated with repertaxin and 2 specific blocking antibodies for CXCR1 or CXCR2. After 3 days, the effect on cell viability and the CSC population was analyzed. A significant reduction of the ALDEFLUOR+ population and cell viability was observed after treatment with repertaxin or anti-CXCR1 antibody, but not with anti-CXCR2 antibody. (D) After 4 days of treatment, the number of apoptotic cells was evaluated, and 36% of apoptotic cells (green) were detected in repertaxin-treated cells compared with controls, in which mostly viable cells (blue) were present. Scale bars: 100 μm. (E) To determine whether cell death was mediated via a bystander effect, CXCR1+ and CXCR1 populations were treated with various concentrations of repertaxin. A decrease in cell viability in CXCR1+ and unsorted populations were detected, whereas no effect was observed in the CXCR1 population. (F) Serial dilutions of dialyzed conditioned medium from CXCR1+ cells treated for 3 days with repertaxin was used to treat sorted CXCR1+, CXCR1, or unsorted populations. After 2 days of treatment, a massive decrease in cell viability was observed in both CXCR1 and unseparated populations, whereas no effect was observed in the CXCR1+ population. Error bars represent mean ± SD.